CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said. https://cnb.cx/48zUuNF
2026-04-14T08:00:16.150Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.